Darren Leonard Reid

This inventor holds 8 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent. Top assignees: Amgen Inc., Cytokinetics, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Darren Leonard Reid. Retrieved from https://idiyas.com/inventor/darren-leonard-reid

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 9)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 7.4

ph-index = 2

Forward Citations = 25(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2022-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12643913 - Mcl-1 inhibitor formulations (2026-06-02),

2. 12421234 - Solid state forms (2025-09-23),

3. 12415806 - Solid state forms (2025-09-16),

4. 12398133 - Solid state forms (2025-08-26),

5. 12252486 - Solid state forms (2025-03-18),

6. 12187700 - Polymorphs and cocrystals of a cardiac troponin activator (2025-01-07),

7. 11827635 - Solid state forms (2023-11-28),

8. 11236091 - Solid state forms (2022-02-01),

Title: The Innovative Contributions of Darren Leonard Reid

Introduction

Darren Leonard Reid is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid-state forms of various compounds. With a total of 8 patents to his name, Reid's work has the potential to impact the treatment of diseases mediated by KRAS G12C inhibition.

Latest Patents

Reid's latest patents focus on the crystalline and amorphous forms of a specific compound, 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-(2-propanyl)-3-pyridinyl)-4-((2S)-2-methyl-4-(2-propenoyl)-1-piperazinyl)pyrido[2,3-d]pyrimidin-2(1H)-one. These patents include several anhydrous, hydrate, and solvate forms, as well as pharmaceutical compositions and methods for treating diseases associated with KRAS G12C inhibition.

Career Highlights

Throughout his career, Reid has worked with prominent companies in the pharmaceutical industry, including Amgen Inc. and Cytokinetics, Inc. His experience in these organizations has allowed him to develop innovative solutions that address critical health challenges.

Collaborations

Reid has collaborated with several professionals in his field, including Mary Chaves and Ron C Kelly. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Darren Leonard Reid's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.